• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

K-ras突变在胰腺肿块细针穿刺抽吸物中的诊断效用。

Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.

作者信息

Villanueva A, Reyes G, Cuatrecasas M, Martínez A, Erill N, Lerma E, Farré A, Lluís F, Capellá G

机构信息

Laboratori d'Investigació Gastrointestinal, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

出版信息

Gastroenterology. 1996 May;110(5):1587-94. doi: 10.1053/gast.1996.v110.pm8613066.

DOI:10.1053/gast.1996.v110.pm8613066
PMID:8613066
Abstract

BACKGROUND & AIMS: Mutations at codon 12 of the K-ras gene are present in 65%-100% of carcinomas of human exocrine pancreas and could be used as a potential tumor marker at the tissue level. The purpose of this study was to assess, in large series of patients, the utility of K-ras mutation analysis to evaluate fine-needle aspirates of pancreatic masses.

METHODS

One hundred fifteen fine-needle aspirates obtained from 93 patients were evaluated retrospectively. Cytological analysis was based on the review of cell blocks. Mutations were detected by using artificial restriction fragment length polymorphisms using the Hphl and BstNl approaches.

RESULTS

The sensitivity and specificity of cell block cytology was 64% and 100%, respectively, for the diagnosis of pancreatic carcinoma. K-ras mutations were detected in 41 pancreatic carcinomas (sensitivity, 59%) and in one mucinous cystic tumor; specificity of ras analysis alone was 100%. The sensitivity of cytology combined with K-ras mutations were 77.6% and 100%, respectively.

CONCLUSIONS

The detection of K-ras mutations would have suggested the diagnosis of pancreatic cancer in 14 cases otherwise not detected by cytology alone. K-ras mutation analysis should be restricted to cell blocks containing suspicious, normal-appearing duct cells, or insufficient material in the cytological examination.

摘要

背景与目的

K-ras基因第12密码子的突变存在于65%-100%的人外分泌性胰腺癌中,可作为组织水平上潜在的肿瘤标志物。本研究的目的是在大量患者中评估K-ras突变分析对评估胰腺肿块细针穿刺抽吸物的效用。

方法

回顾性评估了从93例患者获得的115份细针穿刺抽吸物。细胞学分析基于对细胞块的检查。使用Hphl和BstNl方法通过人工限制性片段长度多态性检测突变。

结果

细胞块细胞学诊断胰腺癌的敏感性和特异性分别为64%和100%。在41例胰腺癌(敏感性59%)和1例黏液性囊性肿瘤中检测到K-ras突变;单独的ras分析特异性为100%。细胞学联合K-ras突变的敏感性分别为77.6%和100%。

结论

K-ras突变的检测可在14例单独细胞学检查未发现的病例中提示胰腺癌的诊断。K-ras突变分析应限于含有可疑的、外观正常的导管细胞或细胞学检查中材料不足的细胞块。

相似文献

1
Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.K-ras突变在胰腺肿块细针穿刺抽吸物中的诊断效用。
Gastroenterology. 1996 May;110(5):1587-94. doi: 10.1053/gast.1996.v110.pm8613066.
2
K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.K-ras基因突变在胰腺肿块超声引导下细针穿刺活检诊断中的应用
World J Gastroenterol. 2003 Jan;9(1):188-91. doi: 10.3748/wjg.v9.i1.188.
3
K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits.
Clin Chem. 1998 Nov;44(11):2243-8.
4
Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.K-ras基因突变检测及胰液细胞学检查在胰腺癌诊断和筛查中的临床应用价值
Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1153-9. doi: 10.1097/00042737-200110000-00006.
5
The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.Ki-ras 突变分析在胰胆肿瘤细胞诊断中的应用
Cancer J. 2000 Sep-Oct;6(5):294-301.
6
Diagnosis of pancreatic lesions using fine needle aspiration cytology: detection of K-ras point mutations using solid phase minisequencing.使用细针穿刺细胞学诊断胰腺病变:采用固相微测序检测K-ras点突变
J Clin Pathol. 1994 Dec;47(12):1082-4. doi: 10.1136/jcp.47.12.1082.
7
Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.通过聚合酶链反应/限制性片段长度多态性分析检测c-Ki-ras突变及胰腺癌诊断
J Natl Cancer Inst. 1993 Dec 15;85(24):2008-12. doi: 10.1093/jnci/85.24.2008.
8
Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.使用经皮技术对外分泌型胰腺癌进行分子诊断。
Ann Surg Oncol. 1996 May;3(3):241-6. doi: 10.1007/BF02306278.
9
Ki-ras mutations and the carcinoembryonic antigen level in fine needle aspirates of the pancreas.
Acta Cytol. 1997 Mar-Apr;41(2):427-34. doi: 10.1159/000332535.
10
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.K-ras癌基因突变表明胰腺囊性肿瘤具有恶性特征。
Ann Surg. 1998 Jul;228(1):79-86. doi: 10.1097/00000658-199807000-00012.

引用本文的文献

1
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients.针对KRAS的RNA干扰疗法联合化疗用于局部晚期胰腺癌患者。
Oncotarget. 2015 Sep 15;6(27):24560-70. doi: 10.18632/oncotarget.4183.
2
Mutant KRAS is a druggable target for pancreatic cancer.KRAS 突变是胰腺癌的一个可用药靶。
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20723-8. doi: 10.1073/pnas.1314307110. Epub 2013 Dec 2.
3
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
检测 K-ras 突变对外分泌胰腺肿瘤诊断的临床有效性:在有临床相关性的患者谱中进行的前瞻性研究。
Eur J Epidemiol. 2011 Mar;26(3):229-36. doi: 10.1007/s10654-011-9547-8. Epub 2011 Feb 6.
4
K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.K-ras癌基因沉默策略可减少肿瘤生长并增强吉西他滨化疗对胰腺癌治疗的疗效。
Cancer Sci. 2007 Jul;98(7):1128-36. doi: 10.1111/j.1349-7006.2007.00506.x. Epub 2007 May 8.
5
[Indications for pancreatic biopsy. Uncommon, but increasingly more important].[胰腺活检的适应证。虽不常见,但越来越重要]
Pathologe. 2005 Feb;26(1):67-72. doi: 10.1007/s00292-004-0736-z.
6
K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.K-ras基因突变在胰腺肿块超声引导下细针穿刺活检诊断中的应用
World J Gastroenterol. 2003 Jan;9(1):188-91. doi: 10.3748/wjg.v9.i1.188.
7
Detection of k-ras gene point mutation in fine needle aspiration and pancreatic juice by sequence special primer method and its clinical significance.序列特异性引物法检测细针穿刺及胰液中k-ras基因点突变及其临床意义
World J Gastroenterol. 2000 Dec;6(6):917-919. doi: 10.3748/wjg.v6.i6.917.
8
K-ras mutations in the bile of patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者胆汁中的K-ras突变
Gut. 2001 Mar;48(3):403-8. doi: 10.1136/gut.48.3.403.
9
Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures.检测胆汁标本中Ki-ras基因点突变以鉴别恶性和良性胆管狭窄。
Gut. 2000 Sep;47(3):357-61. doi: 10.1136/gut.47.3.357.
10
K-Ras mutations and benign pancreatic disease.K-Ras基因突变与胰腺良性疾病
Int J Pancreatol. 2000 Apr;27(2):93-103. doi: 10.1385/IJGC:27:2:093.